Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated other comprehensive income (loss)
Accumulated Deficit
Treasury Shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative effect of adoption of ASU 2016-09 $ 43,843   $ 6   $ 43,837  
Beginning Balance (in shares) at Dec. 31, 2016   86,062       4,975
Beginning Balance at Dec. 31, 2016 384,763 $ 86 534,348 $ (53) (119,260) $ (30,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   640        
Issuance of common stock 13,151 $ 1 13,150      
Issuance of restricted stock (in shares)   100       1,605
Issuance of restricted stock 0 $ 0 (2)     $ 2
Treasury stock purchase, at cost (in shares)           (467)
Treasury stock purchases, at cost (11,008)         $ (11,008)
Stock-based expense 23,983   23,983      
Interest rate swap agreements 73     73    
Foreign currency translation (2)     (2)    
Reclassification of realized loss on cash flow hedge to earnings, net of tax 9     9    
Equity component of convertible notes, net of issuance costs 61,401   61,401      
Purchases of convertible note hedges (62,549)   (62,549)      
Issuance of warrants 31,499   31,499      
Net income 14,408          
Ending Balance (in shares) at Jun. 30, 2017   86,802       3,837
Ending Balance at Jun. 30, 2017 $ 499,571 $ 87 $ 601,836 $ 27 $ (61,015) $ (41,364)